Altos Labs · San Francisco, United StatesAltos Labs
Fundamentalsi
Latest valuationNot disclosed
Credibility rating
Revenue / run rateNot disclosed
StageStartup profile
Latest roundSeries A · $3B
Total funding$3B
Team sizeTeam size not disclosed
LocationSan Francisco, United States
IndustryStartup
Source records1
Ownership data
Cap table not disclosed
Altos Labs does not include shareholding history in the normalized startup source files.
Financial performance
All FinancialsSource snapshot
REVENUE (USD)Not disclosed Not disclosed
FUNDING (USD)$3B Series A · $3B
Insufficient history
Historical revenue and profit series are not present in the source files for this private company.
REVENUE GROWTHVALUE
1Y (TTM)Not disclosed
3Y CAGRNot disclosed
PROFIT GROWTHVALUE
1Y (TTM)Not disclosed
3Y CAGRNot disclosed
About
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed for this purpose. The company was started in 2022.
This profile is normalized from the startup source files. Exact historical financials are shown only when present in the dataset.
Sources
Angel Investors and Venture Capital (1)
InvestorTypeSignal
Founder / employee ownershipBootstrappedNot disclosed in source records
Similar companies
See moreCompanyStartup metricSignal rangeValuationCategory
Enavate SciencesES$300M$300M roundLHNot disclosedValuationStartupStartup
Nightpeak EnergyNE$200M$200M roundLHNot disclosedValuationStartupStartup
Apogee TherapeuticsAT$169M$149M roundLHNot disclosedValuationStartupStartup